Holen Sie sich die Stockscreener-App
0.4199
0.02%
-0.000100
Handel nachbörslich:
.41
-0.0099
-2.36%
Schlusskurs vom Vortag:
$0.42
Offen:
$0.4
24-Stunden-Volumen:
9,668
Relative Volume:
0.08
Marktkapitalisierung:
$58.90M
Einnahmen:
$121.91M
Nettoeinkommen (Verlust:
$1.83M
KGV:
38.52
EPS:
0.0109
Netto-Cashflow:
$7.75M
1W Leistung:
+1.70%
1M Leistung:
-4.57%
6M Leistung:
-38.43%
1J Leistung:
-39.01%
1-Tages-Spanne:
$0.40
$0.4199
1-Wochen-Bereich:
$0.3887
$0.441
52-Wochen-Spanne:
$0.3887
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Firmenname
Xtant Medical Holdings Inc
Sektor
Branche
Telefon
406-388-0480
Adresse
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.4199 | 58.90M | 121.91M | 1.83M | 7.75M | 0.0109 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-05 | Eingeleitet | BTIG Research | Buy |
| 2018-11-15 | Bestätigt | Maxim Group | Buy |
| 2018-02-14 | Bestätigt | Maxim Group | Buy |
Xtant Medical Holdings Inc Aktie (XTNT) Neueste Nachrichten
XTNT stock reflects niche spine focus as regenerative implants underpin the business - ad-hoc-news.de
Xtant Medical Holdings outlines spine surgery focus as investors watch growth path - ad-hoc-news.de
Xtant Medical Holdings Inc (XTNT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
XTNT, Friday review points to sector peers and shares - AD HOC NEWS
Enterprise value to EBITDA forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
Enterprise value to EBIT forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
XTNT Forecast — Price Target — Prediction for 2027 - TradingView
Xtant Medical Holdings, Inc. Actuals & Estimates (AMEX:XTNT) - TradingView
Price to sales forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
Xtant Medical Holdings Inc (XTNT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xtant Medical (NASDAQ: XTNT) details 2026 annual meeting, director slate and pay - Stock Titan
[ARS] Xtant Medical Holdings, Inc. SEC Filing - Stock Titan
Xtant Medical Holdings StockBackground and strategy snapshot - AD HOC NEWS
Xtant Medical Holdings Inc (XTNT) Institutional Confidence - TradingKey
Xtant Medical Holdings Inc (XTNT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Xtant Medical Holdings Inc (XTNT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Xtant Medical Holdings Inc (XTNT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Xtant Medical Holdings Inc (XTNT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Xtant Medical Holdings Inc (XTNT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Xtant Medical Holdings (XTNT) Holds at $0.45 as Micro-Cap Medical Stock Tests Key ResistanceDealer Delta - newsline.com
XTNT Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
XTNT Hovers Near Support Amid Consolidation in Small-Cap MedTechPercent Above MA - newsline.com
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped - Morningstar
XTNT Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Analysis - newsline.com
Xtant Medical Holdings (XTNT) Faces Selling Pressure Near Key Support LevelNew Listing Stocks - dars.gov.et
Xtant Medical Holdings (XTNT) Inches Higher as Stock Consolidates Near Key SupportBPI Bull Correction - The Legal Advocate
Xtant Medical Holdings (XTNT) Tests Key Support Level After Recent DeclineCall Flow Alert - Město Břeclav
Xtant outlines $95M-$99M 2026 revenue outlook as Companion Spine divestiture and Q-code license revenue roll off - MSN
XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Stock GainCommunity Hot Stocks - Newser
QTEX Stock Price and Chart — NASDAQ:QTEX - TradingView
Xtant Medical Holdings Inc. (XTNT) Q1 2026 Earnings: EPS Misses Estimates Amidst Narrow LossSenior Analyst Forecasts - Newser
Xtant Medical Holdings (XTNT) Edges Higher: Testing Key Resistance at $0.50Shared Buy Zones - Newser
Xtant Medical Holdings Holds Near Key Resistance Level After Modest GainCommunity Chart Signals - Newser
Xtant Medical Holdings (XTNT) Gains 2.08% as Stock Approaches Key Resistance at $0.50Profitability Factor - Newser
Xtant Medical Balances New Growth Bets With Near-Term Pain - TipRanks
Xtant Medical launches pre-shaped bone graft product line By Investing.com - Investing.com Nigeria
XTNT SEC FilingsXtant Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Xtant Medical raises FY 2026 revenue guidance to $101M-$105M as it adds HEMOBLAST distribution rights - MSN
Xtant Medical Q1 Earnings Call Highlights - Yahoo Finance
B. Riley Financial | Diversified Financial Services Platform - FinancialContent
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Xtant Medical Holdings’ revenue drops to USD 20.9M in Q1 2026 - Medical Buyer
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2026 Earnings Call Transcript - Insider Monkey
Xtant Medical Holdings, Inc. 2026 Q1 10-Q Report: Financial Results, Strategic Initiatives, and Key Risk Factors - Minichart
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter - TipRanks
Xtant Medical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Xtant Medical Holdings Inc Q1 2026 Earnings: Revenue Misses $20.9 million - technotrenz.com
Xtant Medical Q1 2026 Results: Revenue Guidance Raised, Balance Sheet Strengthened, Exclusive HEMOBLAST® Bellows Distribution Secured 12 - Minichart
Xtant Medical Q1 2026 Earnings Call Transcript - MarketBeat
XTNT: Raised 2026 revenue guidance to $101M–$105M amid new product launches and reduced debt - TradingView
Finanzdaten der Xtant Medical Holdings Inc-Aktie (XTNT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):